Luspatercept for CIA in AML

Clinical trial NCT07663864 · RECRUITING

Trial details

NCT number: NCT07663864
Sponsor: Guangdong Second Provincial General Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chemotherapy-inducing Anemia

Start date: 2026-06-01
Primary completion: 2026-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.